Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

12,000 patients needed to bridge gap between clinical trials and Real-World cancer care

NCT ID NCT06996249

Knowledge-focused Sponsor: Dutch Society of Physicians for Pulmonology and Tuberculosis Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 08, 2026 · Updated 2 times

Summary

This study aims to collect health information from 12,000 adults with lung or other chest cancers. Researchers want to understand why some people respond better to treatment than others, even when their cancer stage is the same. By gathering data from routine care, they hope to improve future treatments and make clinical trial results more useful for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 12,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2025

Expected to finish

Jan 2030

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

All patients diagnosed with a pathological confirmed thoracic malignancy, who are recently diagnosed, or have a strong suspicion without pathological confirmation but with confirmation in the multidisciplinary tumor board in one of the participating hospitals will be asked to participate in this cohort study.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥ 18 years; * Histo/cytopathological proof of a thoracic malignancy, or a strong suspicion (after imaging and multidisciplinary board); * Informed consent for longitudinal observational data collection; Exclusion Criteria: * Mentally challenged patients that are unable to provide conscientious informed consent as determined by the investigator. * Inability to provide a written or electronic informed consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adenocarcinoma are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

adenocarcinoma lung adenocarcinoma lung cancer lung large cell carcinoma lung neoplasm mesothelioma non-small cell lung carcinoma squamous cell carcinoma squamous cell lung carcinoma thoracic cancer thymus cancer Thymus Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Adenocarcinoma Large cell lung cancer Lung cancer Lung cancer, nonsmall cell Mesothelioma Squamous cell carcinoma Thoracic cancer Thymus cancer

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    23 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Amphia Ziekenhuis

    NOT_YET_RECRUITING

    Breda, 4818 CK, Netherlands

  • CWZ (Canisius Wilhelmina Ziekenhuis)

    RECRUITING

    Nijmegen, 6532SZ, Netherlands

  • Deventer Ziekenhuis

    NOT_YET_RECRUITING

    Deventer, 7416 SE, Netherlands

  • Diakonessenhuis

    RECRUITING

    Utrecht, Utrecht, 3582 KE, Netherlands

  • Erasmus MC

    RECRUITING

    Rotterdam, 3015GD, Netherlands

  • Frisius MC

    NOT_YET_RECRUITING

    Leeuwarden, 8934 AD, Netherlands

  • Groene Hart Ziekenhuis

    NOT_YET_RECRUITING

    Gouda, 2803 HH, Netherlands

  • Haga Ziekenhuis

    NOT_YET_RECRUITING

    The Hague, 2545 AA, Netherlands

  • MUMC+

    RECRUITING

    Maastricht, 6229HX, Netherlands

  • Meander MC

    RECRUITING

    Amersfoort, 3813TZ, Netherlands

  • Medisch Spectrum Twente

    NOT_YET_RECRUITING

    Enschede, 7512 KZ, Netherlands

  • Máxima MC

    RECRUITING

    Eindhoven, North Brabant, 5504 DB, Netherlands

  • NKI-AvL

    NOT_YET_RECRUITING

    Amsterdam, 1066 CX, Netherlands

  • Noordwest Ziekenhuisgroep

    NOT_YET_RECRUITING

    Alkmaar, 1815 JD, Netherlands

  • Radboudumc

    NOT_YET_RECRUITING

    Nijmegen, 6525 GA, Netherlands

  • Reinier de Graaf Gasthuis

    NOT_YET_RECRUITING

    Delft, 2625 AD, Netherlands

  • Spaarne Gasthuis

    NOT_YET_RECRUITING

    Hoofddorp, 2134 TM, Netherlands

  • Tergooi MC

    RECRUITING

    Hilversum, Utrecht, 1212 VG, Netherlands

  • UMC Utrecht

    RECRUITING

    Utrecht, 3584 CX, Netherlands

  • UMCG

    NOT_YET_RECRUITING

    Groningen, 9713 GZ, Netherlands

  • Ziekenhuis Gelderse Vallei

    RECRUITING

    Ede, Gelderland, 6716 RP, Netherlands

  • Zuyderland

    RECRUITING

    Sittard, 6162 BG, Netherlands

  • st. Antonius Ziekenhuis

    RECRUITING

    Utrecht, 3543 AZ, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.